Fig. 2From: Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinomaPan-cancer analysis of HM13 expression in TCGA. A HM13 expression in 33 types of cancers. High HM13 expression was related to overall survival and disease-free survival in patients with LGG (B) and LIHC (C)Back to article page